There is growing evidence in support of performing early laparoscopic cholecystectomy (LC) for acute cholecystitis. However, the definition of early LC varies from 0 through 10 days depending on the research protocol. The optimum time to perform early LC is still unclear.
Traditionally, acute cholecystitis has been treated conservatively in the acute phase, with readmission several weeks later for delayed LC. The thought is to allow the initial inflammatory process to subside before surgery and that surgery on inflamed tissue may lead to more complications. However, many studies [5] [6] [7] [8] have failed to support this notion.
Multiple randomized clinical trials report that early LC is safe, with no difference in complications or mortality when compared with delayed LC. [5] [6] [7] [8] All studies [5] [6] [7] [8] found a significant advantage of early LC in reducing hospital stay and lowering cost. One study 8 even found a lower rate of morbidity with early LC. However, in all these studies, the definition of early LC varies significantly, ranging from LC performed within 24 hours to LC performed up to 10 days from presentation. The optimum time for early LC for acute cholecystitis remains elusive. Studying infrequent outcomes within short intervals requires a large sample size. Laparoscopic cholecystectomy is a relatively safe procedure with low morbidity and mortality, and a meta-analysis 5 revealed that many studies are underpowered to examine serious outcomes. Multicenter trials with thousands of patients could provide definitive answers but may not be feasible. In lieu, comparative effectiveness research using large administrative databases may provide important insights. A published analysis 2 of a large database from the Swiss Association of Laparoscopic and Thoracoscopic Surgery found that LC performed within 48 hours was associated with the least amount of complications. However, a major criticism of this study was that patients in whom LC was delayed may have been sicker at presentation, which was not adequately controlled for in the analysis. A similar study 9 that used data from the National Surgical Quality Improvement Program in the United States found no differences in postoperative morbidity for LC performed within a week of presentation. However, in this analysis, all comparisons were made between procedures performed on day 0 vs other days and not among each other. Therefore, the optimal time for intervention was not clearly established. Furthermore, this study did not examine differences in cost.
Our objective was to use the Nationwide Inpatient Sample (NIS) to perform robust comparative effectiveness research analysis to determine the optimum time for early LC. Use of the NIS provides the benefits of a nationally representative data set with enough power to enable adequate risk adjustment and cost analysis.
Methods
We analyzed the NIS admission years 2005 through 2009. The NIS is the largest all-payer inpatient database. 10 Patients were then categorized into 3 groups depending on the number of days from admission to LC. The first group consisted of patients who had their operation performed on days 0 through 1 of presentation, the second group had their operation performed on days 2 though 5 after presentation, and the third group had their operation performed on days 6 through 10 after presentation. The cutoffs for these groups were decided a priori to the analysis after consensus among the authors. They were arbitrarily chosen to reflect clinically relevant cutoff values. The 0-to 1-day group reflects patients taken to the operating room without any delay. The 2-to 5-day group reflects patients among whom delays commonly occur because of logistical reasons, and the 5-to 10-day group consists of patients further delayed possibly because of severity of disease or comorbidities.
We analyzed frequencies and percentages for demographic-and hospital-level characteristics for each group of patients and tested for differences using the χ 2 ), and risk of mortality (as a proxy for severity of illness). Equal weights were applied to each of these factors. The variable for risk of mortality, one of the clinically based severity measurement indexes, is contained in the NIS disease severity subfile and is categorized as minor, moderate, major, and extreme likelihood of death. 13 The All Patient Refined Diagnosis Related
Group is calculated by a health informatics company. It is a grading system in which each patient is assigned a disease severity and mortality risk. Calculations are based on clinical logic that uses disease diagnoses, age, comorbidities, procedures, and other clinically relevant variables. 14 The propensity scores derived from the multinomial logistic regression analysis were further categorized into quintiles. We then used multivariate logistic regression analyses to test for differences in the defined outcomes among the 3 groups. The models were adjusted for demographic differences, including sex, race/ethnicity, primary payer, year of admission, income quartile of patient's residential zip code, and hospital-level characteristics, such as bed size, teaching status, location (rural vs urban), type (government vs private), and propensity score quintiles.
Generalized linear models, with log link (to better achieve linearity through log transformation) and gamma family (given the gamma distribution of the cost data), were used to estimate the adjusted mean costs for the comparison groups. The individual cost of hospitalization was calculated as a product of total charge and hospital-specific cost-charge ratio. Hospital-specific cost-charge ratios are developed using standardized hospital information on all-payer inpatient cost and charge reported by hospitals to the Centers for Medicare & Medicaid Services. By using appropriate Consumer Price Indexes, costs in prior years (2005) (2006) (2007) (2008) were adjusted for inflation and converted to 2009 US dollars. The area wage index was used to control for the influence of local markets on prices. The area wage index is computed by the Centers for Medicare & Medicaid Services to measure relative hospital wage levels by geographic area compared with the national mean.
Given the Poisson distribution of postoperative length-ofstay data, a generalized linear model (with log link and Poisson family) was used to compare adjusted mean postoperative length of stay among the 3 groups. The length-of-stay and cost models were adjusted for complications in addition to the aforementioned variables.
To further delineate the optimum time for LC, we performed 6 separate analyses that dichotomized the data set by days to surgery. Comparisons were made between day 0 vs days 1 through 10, days 0 through 1 vs days 2 through 10, days 0 through 2 vs days 3 through 10, and so on.
Each of these analyses consisted of a 4-step process. First, we performed propensity score matching analysis using multivariable logistic regression to balance the 2 comparison groups on age, comorbidities, and severity of disease and risk of mortality as described above. Second, we performed separate multivariable logistic regression analyses for each outcome variable while adjusting for propensity scores and other covariates. Third, the models were adjusted for sex, race/ethnicity, primary payer, year of admission, income quartile of patient's residential zip code, bed size, teaching status, location (rural vs urban), type (government vs private), and propensity score quintiles. Fourth, we derived adjusted mean cost differences between the 2 comparison groups for each of the day cutoffs using the same methods as described previously.
In addition, we calculated risk-adjusted outcome ratios for each day of surgery. Using the above-mentioned regression model, we predicted the occurrence of the outcome of interest in each patient. This prediction was then used to determine the observed-expected outcome ratio for each day of surgery. Finally, this ratio was multiplied by the mean outcome proportion to determine risk-adjusted outcome ratios for each day. We also derived adjusted mean cost and lengthof-stay differences between the 2 comparison groups for each of the day cutoffs using the same methods as described previously.
For all analyses, discharge-level weights were applied to account for the NIS sampling design and provide for nationally representative estimates. All statistical analyses were performed using STATA software, version 12 (StataCorp).
Results
Of the approximately 5 million patient records in the NIS, 217 932 adults had a primary diagnosis of acute cholecystitis. A total of 193 974 patients (89.0%) were admitted through the emergency department. Of these, 130 189 (67.1%) underwent an LC during the same hospital admission, and 95 523 patients (43.8%) had the operation performed within 10 days of presentation and were included in the analysis.
Most LCs (n = 61 576 [64.5%]) were performed within days 0 through 1 of presentation, whereas 30 838 LCs (32.3%) were performed within days 2 through 5 and 3109 (3.3%) within days 6 through 10 of presentation. Table 1 compares demographic and hospital characteristics among these 3 groups. Patients in the days 0 through 1 group were younger, more likely to be men of white race, and had fewer comorbidities. These patients were more likely to have private insurance and belong to the highest income quartile. They were also less likely to be at large teaching hospitals. Table 2 gives the outcome proportions among the 3 groups. Almost all outcomes (conversions, complications, and mortality) increased as days to procedure increased. Table 3 gives the results of the multivariate analyses after propensity score matching on disease severity for each outcome. Compared with operations performed within days 0 through 1, LCs performed later were associated with a higher likelihood of urinary tract infections, pneumonia, surgical site infections, postoperative length of stay, and hospital costs. The overall mortality rate was 0.41%, and the overall rate of complications was 6.9%.
When each day was analyzed separately ( Figure 1) , patients who underwent LCs within days 0 through 2 had the lowest mortality rates. Also noted was a sudden increase in mortality from 0.37% to 0.45% at day 3 (P < .001). Risk-adjusted complication rates were lowest (6.4%) when the procedure was performed during the day of presentation (day 0) and steadily increased (to 8.1%) as days to the procedure increased (P < .001) (Figure 2 ). An inflection point in the complications curve was noticed after day 3. Because the numbers for bile duct injury and conversions to open surgery were significantly lower than expected, to avoid bias, these factors were removed from the overall complications model. However, a separate sensitivity analysis that included these was performed, and similar results were obtained.
Risk-adjusted mean hospital costs increased almost linearly from $8974 (days 0-1) to $17 745 (days 6-10) as days to procedure increased (Figure 3) . No difference was found in the riskadjusted postoperative length of hospital stay by days to procedure (Figure 4 ).
Discussion
Our study found that LC performed within 2 days of presentation for acute cholecystitis is not only safe but also associated with better outcomes. To our knowledge, this is the largest population-based analysis of studies on outcome differences by time from presentation to surgery for early LCs performed for acute cholecystitis. In this matched analysis of more than 95 000 patients, we found that operations performed within the first 48 hours of presentation were associated with the lowest rates of complications, length of stay, mortality, and hospital cost. Our analysis adds important and compelling evidence in support of very early LC for acute cholecystitis.
Since the late 1980s, LC for acute cholecystitis has been a controversial topic in general surgery practice. Initially, acute cholecystitis was considered a contraindication to LC when surgeons were less experienced with laparoscopic techniques and fearful of operating on inflamed tissue. 15 Subsequently, practices evolved in favor of delayed LC to allow time for the inflammation to "cool off." 16 This process led to initial management by antibiotics and resuscitation followed by elective LC 4 through 6 weeks after the acute attack. For years, with little evidence, delayed LC remained the preference for many surgeons. [17] [18] [19] Some studies 7, 20 have found that harmful effects or failure of conservative management directed attention to early LC. Other studies, 1, 8, 21, 22 including case series, retrospective re- 24 hours of presentation of acute cholecystectomy to delayed LC within days 7 through 45 of presentation. Their analysis revealed LC within 24 hours to be safe and superior to delayed LC. Patients who underwent surgery within 24 hours of admission had lower morbidity (11.8% vs 34.4%), lower mean length of hospital day (by 4.6 days), and lower hospital costs (€2919 vs €4262) (all P < .001). They found no difference in the rate of conversions to open surgery or mortality (one patient died in each arm). Currently, the most debated aspect of the surgical management of acute cholecystitis revolves around the optimum timing of early LC. In general, there is a consensus for surgery to be performed during the same admission. The question remains whether there is a difference in outcomes when surgery is performed within 24 hours, within the next few days, or any time during the same admission. In lieu of a very large prospective multicenter trial, evidence to address such questions can only come from large database studies. Our study is the largest to date on this topic, including more than 95 000 patients.
To the best of our knowledge, the only other large database analysis was conducted by Banz et al, 2 who published data on 4113 patients from the Swiss Association of Laparoscopic and Thoracoscopic Surgery, and by Brooks et al, 9 who used data from 5268 patients in the National Surgical Quality Improvement Program database. Banz et al 2 also found that delaying LC for acute cholecystitis beyond 48 hours of presentation resulted in increased conversions to open surgery, more complications, and longer postoperative hospital stay. However, a major criticism of their study was that patients who underwent surgery later may have been more ill from the outset and therefore had worse outcomes. There was no matching or adjustment on degree of illness. In our study, we used propensity score matching techniques to account for differences in severity of illness. We believe that this kind of matching is an integral component of comparative effectiveness research. The mean complication rate, as indicated by the dashed line, was 6.9%. ety of preoperative variables. In their analysis, they found no significant difference in morbidity and mortality for LCs performed on day 0 vs other days after presentation. However, there was a definite trend of increasing morbidity from 6% on day 0 to 19% for LCs performed after day 4. The lack of statistical significance may in part be due to small sample size.
Another strength of our analysis is that this study has enough power to determine mortality differences after LC. Mortality after LC is very rare and ranges from 0.3% to 1.1%. 2, 8, 9 Mortality after LC in the 2 largest studies 2,9 was only 0.8%
(n = 32 of 4111 patients) 2 and 1.1% (n = 58 of 5268 patients). 9 In our nationally representative analysis, the overall mortality rate was 0.41% with 390 deaths. We found the lowest riskadjusted mortality when LC was performed within 1 day or 2 days of presentation (0.36% and 0.37%, respectively). There was a sudden increase in mortality from day 3 and later (0.45%, P = .01). Of interest, mortality for surgery performed on day 0 was higher at 0.42%. This finding may be explained by operations performed on underresuscitated patients. Patients with acute cholecystitis may present severely dehydrated and at times even in shock. Patients should be adequately resuscitated before surgery. Our study has certain limitations that are worth mentioning. This is a retrospective study of prospectively collected data. Therefore, analysis was limited to available information. For example, we were unable to determine how long patients had symptoms of acute cholecystitis before presentation. Therefore, we did not have a precise measure of duration of disease. As with any national patient database, there are potentially unknown or unreported confounder variables that could not be adjusted for by propensity score matching. While adjusting for severity of illness, we used the All Patient Refined Diagnosis Related Group severity index. Even though this index is widely used and considered to be very accurate and reliable, it is not perfect, and some degree of residual confounding is expected. The Charlson Comorbidity Index is similarly not 100% accurate and has undergone multiple revisions in the past to improve accuracy.
Another limitation is the variation in accuracy and completeness by the coding health care professional. In our analysis, few patients were found to have bile duct injuries (n = 15 [0.02%]) and conversions to open surgery (n = 109 [0.1%]). It is possible that these events were not being adequately documented or reported. Therefore, no conclusions were made based on bile duct injuries or conversions to open surgery. The NIS is not a surgical outcome database; therefore, no stringent protocols are in place to ensure absolute accuracy of coding of postoperative complications. However, because coding of complications is extremely important for hospital reimbursement, it is believed that these complications were captured accurately. Any errors in coding are thought to be evenly distributed among the patient population and thus should not be a cause of major bias for this study.
